Charles Schwab Corporation
SCHW
$97.06
+0.37%
The Charles Schwab Corporation is a leading US retail-oriented financial services firm operating across brokerage, banking, asset management, custody, financial advisory, and wealth management, with approximately $11.9 trillion in client assets as of year-end 2025. It is a dominant platform in Registered Investment Advisor (RIA) custody with over 40% market share, and its economics are driven disproportionately by Charles Schwab Bank and asset management rather than by retail trading commissions. The current investor narrative centers on a powerful earnings recovery: Q2 2026 revenue rose 24.97% year over year to $8.518 billion with EPS of $1.55, as the drag from client cash sorting fades and higher rates rebuild net interest margin. At the same time, the stock has badly lagged the market — down 9.24% over the past month versus a 2.12% gain in SPY — as the Fed's first rate hike since 2023 (September 2026) and intensifying competition from Robinhood and Interactive Brokers keep the debate focused on deposit beta, cash sorting, and whether Schwab's scale advantage can offset share loss in retail trading.…
SCHW
Charles Schwab Corporation
$97.06
Related headlines
Investment Opinion: Should I buy SCHW Today?
We rate SCHW a Hold with a bias toward accumulating on weakness. The analyst consensus is buy (mean 1.78) with an average target of $122.71, implying 26.9% upside, but the stock's severe relative underperformance (-18.96% YTD vs. SPY) and negative free cash flow warrant caution. The core thesis is that the earnings recovery is real but the market is not yet convinced, creating a value opportunity for patient investors.
Supporting evidence includes: 1) Revenue growth of 24.97% YoY in Q2 2026, with net margin expanding to 32.87%; 2) Forward PE of 12.23x, which is below the sector average of 14–18x and the stock's own trailing PE of 21.35x; 3) ROE of 17.91% and operating margin of 43.07%, demonstrating strong profitability; 4) Analyst target upside of 26.9% and a low PEG ratio of 0.381, suggesting growth is not fully priced in. However, free cash flow is negative at -$2.969B TTM, and the dividend yield of 1.32% is modest.
The biggest risks are: 1) Failure to meet forward EPS estimates of $11.15, which would likely trigger a re-rating toward the trailing multiple; 2) Accelerating deposit competition from Robinhood and Interactive Brokers, pressuring net interest margin; 3) A Fed-induced recession that increases credit costs and reduces client assets. The rating would upgrade to Buy if the stock stabilizes above $105 and forward EPS estimates are revised upward, or downgrade to Sell if revenue growth decelerates below 10% or free cash flow remains negative for another two quarters. Relative to its history and peers, SCHW appears undervalued on forward earnings but fairly valued on trailing metrics.
Sign up to view all
SCHW 12-Month Price Forecast
Schwab presents a classic value-versus-momentum dilemma. The fundamental recovery is undeniable: revenue up 24.97% YoY, net margin at 32.87%, and a forward PE of 12.23x that is well below the market and sector averages. However, the stock's persistent underperformance (-18.96% YTD vs. SPY) and negative free cash flow suggest the market is skeptical of the sustainability of these gains. The analyst community remains bullish with a $122.71 average target, but the wide range ($95–$145) reflects deep uncertainty. We would upgrade to bullish if the stock reclaims $105 and forward EPS estimates are revised upward, or downgrade to bearish if it breaks below $90 on rising volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Charles Schwab Corporation's 12-month outlook, with a consensus price target around $123.00 and implied upside of +26.7% versus the current price.
Average Target
$123.00
0 analysts
Implied Upside
+26.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$95 - $150
Analyst target range
Coverage is broad and constructive, with 21 analysts and a consensus recommendation of "buy" (mean rating of 1.78 on a 1–5 scale where 1 is Strong Buy). The average price target of $122.71 implies roughly 26.9% upside from the current price of $96.70, a substantial gap that suggests the sell-side views the recent 9.24% monthly decline as an overreaction rather than a fundamental deterioration. The consensus leans clearly bullish, with recent actions from Morgan Stanley (Overweight), Argus (Buy), Barclays (Overweight), and UBS (Buy) all reaffirming positive ratings through late July 2026.
The target range is wide — from a low of $95.00 (essentially at the current price, implying zero upside) to a high of $145.00 (roughly 50% upside) — a $50 spread that signals meaningful disagreement about the pace of the earnings recovery. The high target likely assumes full normalization of net interest margin, continued double-digit revenue growth, and multiple expansion toward 15–16x forward earnings, while the low target prices in margin compression, deposit competition, and the risk that the Fed's tightening cycle pressures funding costs. Notably, BMO Capital downgraded to Market Perform from Outperform on July 20, 2026, and Piper Sandler remains Neutral — the only two non-bullish voices — suggesting the bear case centers on valuation and competitive dynamics rather than balance-sheet risk. With consensus forward EPS of $11.15 against a $96.70 price, the stock trades at just 8.7x forward earnings, an unusually low multiple that either represents a compelling value opportunity or a market that doubts the estimates — the resolution of that tension will define the next twelve months.
Bulls vs Bears: SCHW Investment Factors
The bull case rests on a powerful earnings recovery (24.97% revenue growth, 32.87% net margin) and a deeply discounted forward PE of 12.23x, with analysts projecting 26.9% upside. The bear case centers on severe relative underperformance (-18.96% YTD vs. SPY), negative free cash flow, and competitive threats from Robinhood and Interactive Brokers. Currently, the bear evidence is stronger on price action and cash flow, but the bull evidence is stronger on fundamentals and valuation. The single most important tension is whether the forward EPS estimate of $11.15 is achievable; if it is, the stock is undervalued, but if estimates are cut, the trailing PE of 21.35x offers little support.
Bullish
- Earnings inflection is real and accelerating: Q2 2026 revenue grew 24.97% YoY to $8.518B, with EPS of $1.55 versus $1.09 in Q2 2025. Net income rose to $2.800B from $2.126B a year earlier, and net margin expanded to 32.87% from 31.19%.
- Forward PE of 12.2x is deeply discounted: The stock trades at 12.23x forward earnings versus a trailing PE of 21.35x, a 42.7% compression. Consensus forward EPS of $11.15 implies the market is pricing in an earnings surge that, if delivered, makes the stock cheap.
- Analyst consensus sees 26.9% upside: 21 analysts rate SCHW a buy (mean 1.78) with an average target of $122.71, implying 26.9% upside from $96.70. Recent reaffirmations from Morgan Stanley, Barclays, and UBS suggest the sell-side views the recent sell-off as overdone.
- Rate hikes boost net interest margin: The Fed's first rate hike since 2023 (September 2026) should widen Schwab's net interest margin as asset yields reprice faster than deposit costs. Interest income already rose to $4.432B in Q2 2026 from $3.787B a year earlier.
Bearish
- Severe relative underperformance vs. market: SCHW is down 9.24% over one month versus SPY's +2.12%, a -11.36% relative gap. Year-to-date, the stock has fallen 4.79% while SPY gained 14.17%, a -18.96% relative shortfall, signaling persistent loss of confidence.
- Negative free cash flow and capital return strain: TTM free cash flow is -$2.969B with operating cash flow of -$2.784B, while the company returned $3.7B in buybacks and dividends in Q2 alone. This reliance on balance-sheet capacity is unsustainable if deposit costs rise further.
- Competitive share loss in retail trading: Robinhood now runs 13 revenue lines above $100M annually, and Interactive Brokers grew accounts 34% YoY. Schwab's retail trading franchise faces intensifying competition, potentially capping revenue growth and pressuring margins.
- Valuation premium on trailing metrics: At 21.35x trailing PE and 3.58x price-to-book, SCHW trades above the typical capital-markets range of 14–18x PE and near the upper end of its historical P/B band (2.39x–4.24x). The stock is not cheap on trailing fundamentals.
SCHW Technical Analysis
Schwab is in a broad range-bound consolidation with a deteriorating short-term tilt, having gained just 2.85% over the past year while the S&P 500 rose 16.0% — a relative strength gap of -13.15 percentage points. At $96.70, the stock sits at roughly 41.6% of its 52-week range of $83.96 to $114.53, meaning it is in the lower-middle portion of its annual band and closer to the lows than the highs. That positioning reflects a market that has repeatedly failed to sustain rallies above $110, but it also means the stock is not technically overextended and retains a defined downside reference at the 52-week low.
Recent momentum has turned decisively negative and is diverging sharply from the longer-term trend: the stock is down 9.24% over one month and 6.23% over three months, even though it is still up 2.85% over twelve months and 2.00% over six months. This divergence — a positive 1-year return undermined by a steep 1-month decline — signals a loss of trend, with the September 2026 slide from $106.88 (September 21) to $96.70 (October 9) representing a roughly 9.5% drawdown in under three weeks. Relative strength versus SPY is negative across every window (-11.36 over 1 month, -9.36 over 3 months, -18.96 year-to-date), confirming persistent underperformance rather than a market-wide pullback, and the 2.55 short ratio suggests short positioning is moderate but not extreme.
Key technical levels are well defined: support rests at the 52-week low of $83.96, roughly 13.2% below the current price, while resistance sits at the 52-week high of $114.53, about 18.4% above. A decisive break below $96 would likely open a path toward the $90–$92 congestion zone from mid-2026, whereas reclaiming $105–$107 would be the first sign of trend repair and a move above $114.53 would confirm a new leg higher. With a beta of 0.782, Schwab is roughly 22% less volatile than the market, which cushions drawdowns but also means it will likely underperform in strong risk-on rallies — a critical consideration for position sizing in a portfolio context. The maximum drawdown of -20.39% over the period further underscores that this is a lower-beta but not low-risk holding.
Beta
0.78
0.78x market volatility
Max Drawdown
-20.4%
Largest decline past year
52-Week Range
$84-$115
Price range past year
Annual Return
+5.5%
Cumulative gain past year
| Period | SCHW Return | S&P 500 |
|---|---|---|
| 1m | -9.5% | +1.8% |
| 3m | -4.0% | +3.5% |
| 6m | -3.2% | +11.2% |
| 1y | +5.5% | +19.1% |
| ytd | -4.4% | +14.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SCHW Fundamental Analysis
Schwab's revenue trajectory is clearly re-accelerating: Q2 2026 revenue of $8.518 billion grew 24.97% year over year, up sequentially from $7.300 billion in Q1 2026 and $7.168 billion in Q4 2025, and well above the $6.816 billion reported in Q2 2025. The multi-quarter arc shows revenue climbing from $6.650 billion in Q1 2025 to $8.518 billion in Q2 2026 — roughly 28% growth over five quarters — driven by both segments, with Investor Services generating $9.919 billion and Advisor Services $2.552 billion. This acceleration implies the cash-sorting headwind that depressed 2024–2025 results has largely run its course, and the investment case now hinges on whether net interest margin expansion can be sustained if the Fed's new tightening cycle lifts rates further.
Profitability is robust and improving: Q2 2026 net income was $2.800 billion on a 32.87% net margin, with gross margin of 83.02% and operating margin of 43.07%. The trend is unmistakably upward — net income rose from $1.909 billion in Q1 2025 to $2.800 billion in Q2 2026, while net margin expanded from 28.71% to 32.87% over the same span and gross margin improved from 84.20% to 83.02% (with Q1 2026 peaking at 88.79%). For a capital-markets firm, a 43% operating margin and 32.9% net margin are strong, reflecting the operating leverage inherent in Schwab's scale, though the sequential dip in gross margin from Q1's 88.79% to Q2's 83.02% bears watching as a potential sign of rising funding costs.
Balance sheet and cash flow metrics present a mixed picture: debt-to-equity is a manageable 0.626, ROE is 17.91%, and ROA is a thin 2.07% — typical for a bank-heavy model — while the current ratio of 0.530 reflects the balance-sheet structure of a financial institution rather than a liquidity warning. Free cash flow is volatile and currently negative on a TTM basis at -$2.969 billion in Q2 2026, with operating cash flow of -$2.784 billion, driven by working-capital swings and $3.054 billion of stock repurchases plus $643 million of dividends. The company returned substantial capital ($3.7 billion in buybacks and dividends in Q2 alone) while holding $40.58 billion in cash, but the negative FCF and 19.01 price-to-cash-flow ratio suggest the company is currently relying on balance-sheet capacity rather than internal cash generation to fund shareholder returns — a dynamic that would become a concern if deposit costs rise further.
Quarterly Revenue
$8.5B
2026-06
Revenue YoY Growth
+25.0%
YoY Comparison
Gross Margin
83.0%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SCHW Overvalued?
Because Schwab is solidly profitable — Q2 2026 net income of $2.800 billion and trailing EPS of $1.55 — the PE ratio is the appropriate primary metric. The stock trades at a trailing PE of 21.35x versus a forward PE of 12.23x, an unusually wide 42.7% compression that implies the market expects earnings to grow dramatically — consistent with consensus EPS estimates of $11.15 for the forward period versus the current run-rate. That gap is the single most important valuation signal here: if forward estimates are met, the stock is cheap; if they slip, the trailing multiple offers little cushion.
Relative to the broader financial sector, Schwab's 21.35x trailing PE sits at a premium to the typical capital-markets/brokerage range of roughly 14–18x, while its 3.58 price-to-book and 6.40 price-to-sales are elevated for a bank-heavy model. The PEG ratio of 0.381 is strikingly low, suggesting the market is not paying up for growth — a function of the depressed trailing earnings base rather than genuine undervaluation. The 1.32% dividend yield and 26.31% payout ratio are modest but sustainable, and the 12.63 EV/EBITDA is reasonable for a scaled financial platform, though the 5.885 EV/Sales reflects the revenue-heavy, margin-light nature of the banking segment.
Historically, Schwab's PE has ranged from roughly 14.9x (Q2 2026) to 33.7x (Q4 2023), with the current 21.35x sitting near the middle of that band but well above the 14.9x trough recorded just last quarter. The price-to-book of 3.58 is near the upper end of its historical range (2.39x in Q3 2021 to 4.24x in Q4 2022), indicating the market is pricing in meaningful book-value growth and margin recovery. In short, the stock is not at a historical extreme, but it is no longer cheap on trailing metrics — the bull case now rests almost entirely on the forward earnings inflection materializing.
PE
21.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 15x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. Negative TTM free cash flow of -$2.969B and operating cash flow of -$2.784B, combined with $3.7B in quarterly capital returns, mean Schwab is funding shareholder returns from its balance sheet rather than internal cash generation. The current ratio of 0.53 is typical for a bank but leaves little liquidity buffer if deposit outflows accelerate. Additionally, the sequential gross margin decline from 88.79% in Q1 2026 to 83.02% in Q2 suggests rising funding costs, which could compress net interest margin if the Fed's tightening cycle intensifies deposit competition.
Market and competitive risks are elevated. The stock's beta of 0.782 means it is less volatile than the market, but it has still underperformed SPY by -18.96% YTD, indicating company-specific headwinds. Robinhood's rapid product diversification (13 revenue lines above $100M) and Interactive Brokers' 34% account growth threaten Schwab's retail trading and wealth management franchises. Regulatory risks include potential changes to payment for order flow or fiduciary rules, though these are not imminent. The Fed's first rate hike since 2023 (September 2026) could trigger a 14% average S&P 500 drawdown within 12 months, per historical patterns, which would likely drag Schwab despite its lower beta.
In a worst-case scenario, a combination of deposit cost acceleration, forward EPS misses, and a broad market sell-off could drive the stock to its 52-week low of $83.96, representing a 13.2% decline from the current price of $96.70. If the Fed's tightening cycle causes a recession and credit losses emerge, the stock could fall further to the analyst low target of $95.00, though that is above the 52-week low. A more severe scenario, such as a 20% market correction and multiple compression to 10x forward earnings, could push the stock below $80, implying a loss of 17% or more. The maximum drawdown over the past period was -20.39%, so investors should be prepared for at least a 20% drawdown in adverse conditions.
FAQ
The most severe risk is financial: negative TTM free cash flow of -$2.969B and operating cash flow of -$2.784B, while returning $3.7B to shareholders in Q2 alone, which relies on balance-sheet capacity. Competitive risk is high, with Robinhood and Interactive Brokers growing accounts rapidly and threatening Schwab's retail trading share. Macro risk includes the Fed's tightening cycle, which could increase deposit costs and compress net interest margin, as hinted by the sequential gross margin dip from 88.79% to 83.02%. Company-specific risk centers on the forward EPS estimate of $11.15; a miss would likely trigger a sharp re-rating. Ranked by severity: financial, competitive, macro, company-specific.
Our 12-month forecast has three scenarios: a base case (50% probability) with a target range of $105–$122.71, assuming EPS of $11.15 is met and the stock trades at 13–15x forward earnings; a bull case (30% probability) targeting $122.71–$145.00, driven by an earnings beat and multiple expansion; and a bear case (20% probability) targeting $83.96–$95.00, assuming a recession and EPS cuts. The base case is most likely, hinging on the Fed achieving a soft landing and Schwab delivering on its forward estimates. The key assumption is that net interest margin expands without a spike in deposit costs.
SCHW appears undervalued on forward earnings but fairly valued on trailing metrics. The forward PE of 12.23x is a 42.7% discount to the trailing PE of 21.35x, implying the market expects a massive earnings surge. Relative to peers in capital markets (typically 14–18x PE), the forward multiple is cheap, but the price-to-book of 3.58x is near the upper end of its historical range (2.39x–4.24x). The market is pricing in a successful earnings recovery; if that materializes, the stock is undervalued, but if estimates are cut, the trailing multiple offers little support.
From a risk/reward perspective, SCHW offers a favorable setup for value-oriented investors. The stock trades at 12.23x forward earnings, well below its trailing PE of 21.35x and the sector average of 14–18x, while analysts see 26.9% upside to their average target of $122.71. However, the biggest downside risk is a failure to meet the consensus EPS of $11.15, which could drive the stock to the 52-week low of $83.96, a 13.2% decline. Given the negative free cash flow and competitive pressures, it is a good buy only for those with a 12–18 month horizon who can withstand a potential 15–20% drawdown.
SCHW is better suited for long-term investment (minimum 12–18 months) than short-term trading. Its beta of 0.782 means it is less volatile than the market, but it has still suffered a -20.39% maximum drawdown and is down 9.24% in the past month, making it risky for short-term traders. The dividend yield of 1.32% and payout ratio of 26.31% provide modest income, but the real return potential comes from multiple expansion as the earnings recovery is recognized. Earnings visibility is moderate, with 21 analysts covering and a consensus buy rating. A long-term holder can ride out quarterly volatility and benefit from the projected 26.9% upside to analyst targets.